Industry Research Reports
Home > Reports > Service & Software > Global ELISA Assay Service Market Outlook, In‑Depth Analysis & Forecast to 2032
Global ELISA Assay Service Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Service & Software
Published Date: 2026-03-26
Pages: 161 Pages
Report ld: 6319791
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global ELISA Assay Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Disease Diagnosis accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
ELISA Assay Service leading players (including Boster Bio, RayBiotech, R&D Systems, Inc, ELISA Technologies, Inc., Cellular Technology Limited, Virology Research Services Ltd, Chimera Biotec, NorthEast BioLab, Sino Biological, Inc, Kaneka Eurogentec S.A., etc.), dominate supply; the top five capture approximately % of global revenue, with Boster Bio leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global ELISA Assay Service market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Boster Bio
- RayBiotech
- R&D Systems, Inc
- ELISA Technologies, Inc.
- Cellular Technology Limited
- Virology Research Services Ltd
- Chimera Biotec
- NorthEast BioLab
- Sino Biological, Inc
- Kaneka Eurogentec S.A.
- Prove Laboratory Services
- KCAS Bio
- BioCat GmbH
- Aviva Systems Biology Corporation
- Eve Technologies
- Boster Biological Technology
- Bio-Techne
- Precision Medicine Group, LLC
- ACROBiosystems
- mabtech
- Cellular Technology Limited（immunospot）
- Pestka Biomedical Laboratories, Inc
- ProteoGenix
- Kaneka Eurogentec S.A
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Direct ELISA
- Indirect ELISA
Segment by Application
- Disease Diagnosis
- Vaccine Effectiveness Evaluation
- Drug Development
- Allergen Testing
- Others
CHAPTER OUTLINE
Chapter 1: Defines the ELISA Assay Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to ELISA Assay Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global ELISA Assay Service Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Direct ELISA
1.2.3 Indirect ELISA
1.3 Market Segmentation by Application
1.3.1 Global ELISA Assay Service Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Disease Diagnosis
1.3.3 Vaccine Effectiveness Evaluation
1.3.4 Drug Development
1.3.5 Allergen Testing
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global ELISA Assay Service Revenue Estimates and Forecasts (2021-2032)
2.2 Global ELISA Assay Service Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global ELISA Assay Service Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global ELISA Assay Service Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Direct ELISA: Market Share by Key Players
3.3.2 Indirect ELISA: Market Share by Key Players
3.4 Global ELISA Assay Service Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global ELISA Assay Service Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global ELISA Assay Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America ELISA Assay Service Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America ELISA Assay Service Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe ELISA Assay Service Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe ELISA Assay Service Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific ELISA Assay Service Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific ELISA Assay Service Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America ELISA Assay Service Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America ELISA Assay Service Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa ELISA Assay Service Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa ELISA Assay Service Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Boster Bio
11.1.1 Boster Bio Corporation Information
11.1.2 Boster Bio Business Overview
11.1.3 Boster Bio ELISA Assay Service Product Features and Attributes
11.1.4 Boster Bio ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.1.5 Boster Bio ELISA Assay Service Revenue by Product in 2025
11.1.6 Boster Bio ELISA Assay Service Revenue by Application in 2025
11.1.7 Boster Bio ELISA Assay Service Revenue by Geographic Area in 2025
11.1.8 Boster Bio ELISA Assay Service SWOT Analysis
11.1.9 Boster Bio Recent Developments
11.2 RayBiotech
11.2.1 RayBiotech Corporation Information
11.2.2 RayBiotech Business Overview
11.2.3 RayBiotech ELISA Assay Service Product Features and Attributes
11.2.4 RayBiotech ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.2.5 RayBiotech ELISA Assay Service Revenue by Product in 2025
11.2.6 RayBiotech ELISA Assay Service Revenue by Application in 2025
11.2.7 RayBiotech ELISA Assay Service Revenue by Geographic Area in 2025
11.2.8 RayBiotech ELISA Assay Service SWOT Analysis
11.2.9 RayBiotech Recent Developments
11.3 R&D Systems, Inc
11.3.1 R&D Systems, Inc Corporation Information
11.3.2 R&D Systems, Inc Business Overview
11.3.3 R&D Systems, Inc ELISA Assay Service Product Features and Attributes
11.3.4 R&D Systems, Inc ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.3.5 R&D Systems, Inc ELISA Assay Service Revenue by Product in 2025
11.3.6 R&D Systems, Inc ELISA Assay Service Revenue by Application in 2025
11.3.7 R&D Systems, Inc ELISA Assay Service Revenue by Geographic Area in 2025
11.3.8 R&D Systems, Inc ELISA Assay Service SWOT Analysis
11.3.9 R&D Systems, Inc Recent Developments
11.4 ELISA Technologies, Inc.
11.4.1 ELISA Technologies, Inc. Corporation Information
11.4.2 ELISA Technologies, Inc. Business Overview
11.4.3 ELISA Technologies, Inc. ELISA Assay Service Product Features and Attributes
11.4.4 ELISA Technologies, Inc. ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.4.5 ELISA Technologies, Inc. ELISA Assay Service Revenue by Product in 2025
11.4.6 ELISA Technologies, Inc. ELISA Assay Service Revenue by Application in 2025
11.4.7 ELISA Technologies, Inc. ELISA Assay Service Revenue by Geographic Area in 2025
11.4.8 ELISA Technologies, Inc. ELISA Assay Service SWOT Analysis
11.4.9 ELISA Technologies, Inc. Recent Developments
11.5 Cellular Technology Limited
11.5.1 Cellular Technology Limited Corporation Information
11.5.2 Cellular Technology Limited Business Overview
11.5.3 Cellular Technology Limited ELISA Assay Service Product Features and Attributes
11.5.4 Cellular Technology Limited ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.5.5 Cellular Technology Limited ELISA Assay Service Revenue by Product in 2025
11.5.6 Cellular Technology Limited ELISA Assay Service Revenue by Application in 2025
11.5.7 Cellular Technology Limited ELISA Assay Service Revenue by Geographic Area in 2025
11.5.8 Cellular Technology Limited ELISA Assay Service SWOT Analysis
11.5.9 Cellular Technology Limited Recent Developments
11.6 Virology Research Services Ltd
11.6.1 Virology Research Services Ltd Corporation Information
11.6.2 Virology Research Services Ltd Business Overview
11.6.3 Virology Research Services Ltd ELISA Assay Service Product Features and Attributes
11.6.4 Virology Research Services Ltd ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.6.5 Virology Research Services Ltd Recent Developments
11.7 Chimera Biotec
11.7.1 Chimera Biotec Corporation Information
11.7.2 Chimera Biotec Business Overview
11.7.3 Chimera Biotec ELISA Assay Service Product Features and Attributes
11.7.4 Chimera Biotec ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.7.5 Chimera Biotec Recent Developments
11.8 NorthEast BioLab
11.8.1 NorthEast BioLab Corporation Information
11.8.2 NorthEast BioLab Business Overview
11.8.3 NorthEast BioLab ELISA Assay Service Product Features and Attributes
11.8.4 NorthEast BioLab ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.8.5 NorthEast BioLab Recent Developments
11.9 Sino Biological, Inc
11.9.1 Sino Biological, Inc Corporation Information
11.9.2 Sino Biological, Inc Business Overview
11.9.3 Sino Biological, Inc ELISA Assay Service Product Features and Attributes
11.9.4 Sino Biological, Inc ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.9.5 Sino Biological, Inc Recent Developments
11.10 Kaneka Eurogentec S.A.
11.10.1 Kaneka Eurogentec S.A. Corporation Information
11.10.2 Kaneka Eurogentec S.A. Business Overview
11.10.3 Kaneka Eurogentec S.A. ELISA Assay Service Product Features and Attributes
11.10.4 Kaneka Eurogentec S.A. ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Prove Laboratory Services
11.11.1 Prove Laboratory Services Corporation Information
11.11.2 Prove Laboratory Services Business Overview
11.11.3 Prove Laboratory Services ELISA Assay Service Product Features and Attributes
11.11.4 Prove Laboratory Services ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.11.5 Prove Laboratory Services Recent Developments
11.12 KCAS Bio
11.12.1 KCAS Bio Corporation Information
11.12.2 KCAS Bio Business Overview
11.12.3 KCAS Bio ELISA Assay Service Product Features and Attributes
11.12.4 KCAS Bio ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.12.5 KCAS Bio Recent Developments
11.13 BioCat GmbH
11.13.1 BioCat GmbH Corporation Information
11.13.2 BioCat GmbH Business Overview
11.13.3 BioCat GmbH ELISA Assay Service Product Features and Attributes
11.13.4 BioCat GmbH ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.13.5 BioCat GmbH Recent Developments
11.14 Aviva Systems Biology Corporation
11.14.1 Aviva Systems Biology Corporation Corporation Information
11.14.2 Aviva Systems Biology Corporation Business Overview
11.14.3 Aviva Systems Biology Corporation ELISA Assay Service Product Features and Attributes
11.14.4 Aviva Systems Biology Corporation ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.14.5 Aviva Systems Biology Corporation Recent Developments
11.15 Eve Technologies
11.15.1 Eve Technologies Corporation Information
11.15.2 Eve Technologies Business Overview
11.15.3 Eve Technologies ELISA Assay Service Product Features and Attributes
11.15.4 Eve Technologies ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.15.5 Eve Technologies Recent Developments
11.16 Boster Biological Technology
11.16.1 Boster Biological Technology Corporation Information
11.16.2 Boster Biological Technology Business Overview
11.16.3 Boster Biological Technology ELISA Assay Service Product Features and Attributes
11.16.4 Boster Biological Technology ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.16.5 Boster Biological Technology Recent Developments
11.17 Bio-Techne
11.17.1 Bio-Techne Corporation Information
11.17.2 Bio-Techne Business Overview
11.17.3 Bio-Techne ELISA Assay Service Product Features and Attributes
11.17.4 Bio-Techne ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.17.5 Bio-Techne Recent Developments
11.18 Precision Medicine Group, LLC
11.18.1 Precision Medicine Group, LLC Corporation Information
11.18.2 Precision Medicine Group, LLC Business Overview
11.18.3 Precision Medicine Group, LLC ELISA Assay Service Product Features and Attributes
11.18.4 Precision Medicine Group, LLC ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.18.5 Precision Medicine Group, LLC Recent Developments
11.19 ACROBiosystems
11.19.1 ACROBiosystems Corporation Information
11.19.2 ACROBiosystems Business Overview
11.19.3 ACROBiosystems ELISA Assay Service Product Features and Attributes
11.19.4 ACROBiosystems ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.19.5 ACROBiosystems Recent Developments
11.20 mabtech
11.20.1 mabtech Corporation Information
11.20.2 mabtech Business Overview
11.20.3 mabtech ELISA Assay Service Product Features and Attributes
11.20.4 mabtech ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.20.5 mabtech Recent Developments
11.21 Cellular Technology Limited（immunospot）
11.21.1 Cellular Technology Limited（immunospot） Corporation Information
11.21.2 Cellular Technology Limited（immunospot） Business Overview
11.21.3 Cellular Technology Limited（immunospot） ELISA Assay Service Product Features and Attributes
11.21.4 Cellular Technology Limited（immunospot） ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.21.5 Cellular Technology Limited（immunospot） Recent Developments
11.22 Pestka Biomedical Laboratories, Inc
11.22.1 Pestka Biomedical Laboratories, Inc Corporation Information
11.22.2 Pestka Biomedical Laboratories, Inc Business Overview
11.22.3 Pestka Biomedical Laboratories, Inc ELISA Assay Service Product Features and Attributes
11.22.4 Pestka Biomedical Laboratories, Inc ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.22.5 Pestka Biomedical Laboratories, Inc Recent Developments
11.23 ProteoGenix
11.23.1 ProteoGenix Corporation Information
11.23.2 ProteoGenix Business Overview
11.23.3 ProteoGenix ELISA Assay Service Product Features and Attributes
11.23.4 ProteoGenix ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.23.5 ProteoGenix Recent Developments
11.24 Kaneka Eurogentec S.A
11.24.1 Kaneka Eurogentec S.A Corporation Information
11.24.2 Kaneka Eurogentec S.A Business Overview
11.24.3 Kaneka Eurogentec S.A ELISA Assay Service Product Features and Attributes
11.24.4 Kaneka Eurogentec S.A ELISA Assay Service Revenue and Gross Margin (2021-2026)
11.24.5 Kaneka Eurogentec S.A Recent Developments
12 ELISA Assay Service Value Chain and Ecosystem Analysis
12.1 ELISA Assay Service Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 ELISA Assay Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global ELISA Assay Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global ELISA Assay Service Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global ELISA Assay Service Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global ELISA Assay Service Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global ELISA Assay Service Revenue by Region (US$ Million), 2021-2026
Table 5. Global ELISA Assay Service Revenue by Region (US$ Million), 2027-2032
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 7. Global ELISA Assay Service Revenue by Players (US$ Million), 2021-2026
Table 8. Global ELISA Assay Service Revenue-Based Market Share by Players (2021-2026)
Table 9. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 10. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on ELISA Assay Service Revenue, 2025
Table 11. Global ELISA Assay Service Average Gross Margin (%) by Player (2021 vs 2025)
Table 12. Global ELISA Assay Service Companies Headquarters
Table 13. Global ELISA Assay Service Market Concentration Ratio (CR5)
Table 14. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global ELISA Assay Service Revenue by Type (US$ Million), 2021-2026
Table 17. Global ELISA Assay Service Revenue by Type (US$ Million), 2027-2032
Table 18. Key Product Attributes and Differentiation
Table 19. Global ELISA Assay Service Revenue by Application (US$ Million), 2021-2026
Table 20. Global ELISA Assay Service Revenue by Application (US$ Million), 2027-2032
Table 21. ELISA Assay Service High-Growth Sectors Demand CAGR (2026-2032)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America ELISA Assay Service Growth Accelerators and Market Barriers
Table 25. North America ELISA Assay Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 26. Europe ELISA Assay Service Growth Accelerators and Market Barriers
Table 27. Europe ELISA Assay Service Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. Asia-Pacific ELISA Assay Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific ELISA Assay Service Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 30. Central and South America ELISA Assay Service Investment Opportunities and Key Challenges
Table 31. Central and South America ELISA Assay Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Middle East and Africa ELISA Assay Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa ELISA Assay Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 34. Boster Bio Corporation Information
Table 35. Boster Bio Description and Major Businesses
Table 36. Boster Bio Product Features and Attributes
Table 37. Boster Bio Revenue (US$ Million) and Gross Margin (2021-2026)
Table 38. Boster Bio Revenue Proportion by Product in 2025
Table 39. Boster Bio Revenue Proportion by Application in 2025
Table 40. Boster Bio Revenue Proportion by Geographic Area in 2025
Table 41. Boster Bio ELISA Assay Service SWOT Analysis
Table 42. Boster Bio Recent Developments
Table 43. RayBiotech Corporation Information
Table 44. RayBiotech Description and Major Businesses
Table 45. RayBiotech Product Features and Attributes
Table 46. RayBiotech Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. RayBiotech Revenue Proportion by Product in 2025
Table 48. RayBiotech Revenue Proportion by Application in 2025
Table 49. RayBiotech Revenue Proportion by Geographic Area in 2025
Table 50. RayBiotech ELISA Assay Service SWOT Analysis
Table 51. RayBiotech Recent Developments
Table 52. R&D Systems, Inc Corporation Information
Table 53. R&D Systems, Inc Description and Major Businesses
Table 54. R&D Systems, Inc Product Features and Attributes
Table 55. R&D Systems, Inc Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. R&D Systems, Inc Revenue Proportion by Product in 2025
Table 57. R&D Systems, Inc Revenue Proportion by Application in 2025
Table 58. R&D Systems, Inc Revenue Proportion by Geographic Area in 2025
Table 59. R&D Systems, Inc ELISA Assay Service SWOT Analysis
Table 60. R&D Systems, Inc Recent Developments
Table 61. ELISA Technologies, Inc. Corporation Information
Table 62. ELISA Technologies, Inc. Description and Major Businesses
Table 63. ELISA Technologies, Inc. Product Features and Attributes
Table 64. ELISA Technologies, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. ELISA Technologies, Inc. Revenue Proportion by Product in 2025
Table 66. ELISA Technologies, Inc. Revenue Proportion by Application in 2025
Table 67. ELISA Technologies, Inc. Revenue Proportion by Geographic Area in 2025
Table 68. ELISA Technologies, Inc. ELISA Assay Service SWOT Analysis
Table 69. ELISA Technologies, Inc. Recent Developments
Table 70. Cellular Technology Limited Corporation Information
Table 71. Cellular Technology Limited Description and Major Businesses
Table 72. Cellular Technology Limited Product Features and Attributes
Table 73. Cellular Technology Limited Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. Cellular Technology Limited Revenue Proportion by Product in 2025
Table 75. Cellular Technology Limited Revenue Proportion by Application in 2025
Table 76. Cellular Technology Limited Revenue Proportion by Geographic Area in 2025
Table 77. Cellular Technology Limited ELISA Assay Service SWOT Analysis
Table 78. Cellular Technology Limited Recent Developments
Table 79. Virology Research Services Ltd Corporation Information
Table 80. Virology Research Services Ltd Description and Major Businesses
Table 81. Virology Research Services Ltd Product Features and Attributes
Table 82. Virology Research Services Ltd Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Virology Research Services Ltd Recent Developments
Table 84. Chimera Biotec Corporation Information
Table 85. Chimera Biotec Description and Major Businesses
Table 86. Chimera Biotec Product Features and Attributes
Table 87. Chimera Biotec Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. Chimera Biotec Recent Developments
Table 89. NorthEast BioLab Corporation Information
Table 90. NorthEast BioLab Description and Major Businesses
Table 91. NorthEast BioLab Product Features and Attributes
Table 92. NorthEast BioLab Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. NorthEast BioLab Recent Developments
Table 94. Sino Biological, Inc Corporation Information
Table 95. Sino Biological, Inc Description and Major Businesses
Table 96. Sino Biological, Inc Product Features and Attributes
Table 97. Sino Biological, Inc Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. Sino Biological, Inc Recent Developments
Table 99. Kaneka Eurogentec S.A. Corporation Information
Table 100. Kaneka Eurogentec S.A. Description and Major Businesses
Table 101. Kaneka Eurogentec S.A. Product Features and Attributes
Table 102. Kaneka Eurogentec S.A. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. Kaneka Eurogentec S.A. Recent Developments
Table 104. Prove Laboratory Services Corporation Information
Table 105. Prove Laboratory Services Description and Major Businesses
Table 106. Prove Laboratory Services Product Features and Attributes
Table 107. Prove Laboratory Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 108. Prove Laboratory Services Recent Developments
Table 109. KCAS Bio Corporation Information
Table 110. KCAS Bio Description and Major Businesses
Table 111. KCAS Bio Product Features and Attributes
Table 112. KCAS Bio Revenue (US$ Million) and Gross Margin (2021-2026)
Table 113. KCAS Bio Recent Developments
Table 114. BioCat GmbH Corporation Information
Table 115. BioCat GmbH Description and Major Businesses
Table 116. BioCat GmbH Product Features and Attributes
Table 117. BioCat GmbH Revenue (US$ Million) and Gross Margin (2021-2026)
Table 118. BioCat GmbH Recent Developments
Table 119. Aviva Systems Biology Corporation Corporation Information
Table 120. Aviva Systems Biology Corporation Description and Major Businesses
Table 121. Aviva Systems Biology Corporation Product Features and Attributes
Table 122. Aviva Systems Biology Corporation Revenue (US$ Million) and Gross Margin (2021-2026)
Table 123. Aviva Systems Biology Corporation Recent Developments
Table 124. Eve Technologies Corporation Information
Table 125. Eve Technologies Description and Major Businesses
Table 126. Eve Technologies Product Features and Attributes
Table 127. Eve Technologies Revenue (US$ Million) and Gross Margin (2021-2026)
Table 128. Eve Technologies Recent Developments
Table 129. Boster Biological Technology Corporation Information
Table 130. Boster Biological Technology Description and Major Businesses
Table 131. Boster Biological Technology Product Features and Attributes
Table 132. Boster Biological Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 133. Boster Biological Technology Recent Developments
Table 134. Bio-Techne Corporation Information
Table 135. Bio-Techne Description and Major Businesses
Table 136. Bio-Techne Product Features and Attributes
Table 137. Bio-Techne Revenue (US$ Million) and Gross Margin (2021-2026)
Table 138. Bio-Techne Recent Developments
Table 139. Precision Medicine Group, LLC Corporation Information
Table 140. Precision Medicine Group, LLC Description and Major Businesses
Table 141. Precision Medicine Group, LLC Product Features and Attributes
Table 142. Precision Medicine Group, LLC Revenue (US$ Million) and Gross Margin (2021-2026)
Table 143. Precision Medicine Group, LLC Recent Developments
Table 144. ACROBiosystems Corporation Information
Table 145. ACROBiosystems Description and Major Businesses
Table 146. ACROBiosystems Product Features and Attributes
Table 147. ACROBiosystems Revenue (US$ Million) and Gross Margin (2021-2026)
Table 148. ACROBiosystems Recent Developments
Table 149. mabtech Corporation Information
Table 150. mabtech Description and Major Businesses
Table 151. mabtech Product Features and Attributes
Table 152. mabtech Revenue (US$ Million) and Gross Margin (2021-2026)
Table 153. mabtech Recent Developments
Table 154. Cellular Technology Limited（immunospot） Corporation Information
Table 155. Cellular Technology Limited（immunospot） Description and Major Businesses
Table 156. Cellular Technology Limited（immunospot） Product Features and Attributes
Table 157. Cellular Technology Limited（immunospot） Revenue (US$ Million) and Gross Margin (2021-2026)
Table 158. Cellular Technology Limited（immunospot） Recent Developments
Table 159. Pestka Biomedical Laboratories, Inc Corporation Information
Table 160. Pestka Biomedical Laboratories, Inc Description and Major Businesses
Table 161. Pestka Biomedical Laboratories, Inc Product Features and Attributes
Table 162. Pestka Biomedical Laboratories, Inc Revenue (US$ Million) and Gross Margin (2021-2026)
Table 163. Pestka Biomedical Laboratories, Inc Recent Developments
Table 164. ProteoGenix Corporation Information
Table 165. ProteoGenix Description and Major Businesses
Table 166. ProteoGenix Product Features and Attributes
Table 167. ProteoGenix Revenue (US$ Million) and Gross Margin (2021-2026)
Table 168. ProteoGenix Recent Developments
Table 169. Kaneka Eurogentec S.A Corporation Information
Table 170. Kaneka Eurogentec S.A Description and Major Businesses
Table 171. Kaneka Eurogentec S.A Product Features and Attributes
Table 172. Kaneka Eurogentec S.A Revenue (US$ Million) and Gross Margin (2021-2026)
Table 173. Kaneka Eurogentec S.A Recent Developments
Table 174. Technologies, Platforms and Infrastructure
Table 175. Distributors List
Table 176. Market Trends and Market Evolution
Table 177. Market Drivers and Opportunities
Table 178. Market Challenges, Risks, and Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ELISA Assay Service Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Direct ELISA Product Picture
Figure 3. Indirect ELISA Product Picture
Figure 4. Global ELISA Assay Service Market Size Growth Rate , 2021 vs 2025 vs 2032 (US$ Million)
Figure 5. Global ELISA Assay Service Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Disease Diagnosis
Figure 7. Vaccine Effectiveness Evaluation
Figure 8. Drug Development
Figure 9. Allergen Testing
Figure 10. Others
Figure 11. ELISA Assay Service Report Years Considered
Figure 12. Global ELISA Assay Service Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 14. Global ELISA Assay Service Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Global ELISA Assay Service Revenue-Based Market Share by Region (2021-2032)
Figure 16. Global ELISA Assay Service Revenue-Based Market Share Ranking (2025)
Figure 17. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 18. Direct ELISA Revenue-Based Market Share by Player in 2025
Figure 19. Indirect ELISA Revenue-Based Market Share by Player in 2025
Figure 20. Global ELISA Assay Service Revenue-Based Market Share by Type (2021-2032)
Figure 21. Global ELISA Assay Service Revenue-Based Market Share by Application (2021-2032)
Figure 22. North America ELISA Assay Service Revenue YoY (US$ Million), 2021-2032
Figure 23. North America Top 5 Players ELISA Assay Service Revenue (US$ Million) in 2025
Figure 24. North America ELISA Assay Service Revenue (US$ Million) by Application (2021-2032)
Figure 25. US ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 26. Canada ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 27. Mexico ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 28. Europe ELISA Assay Service Revenue YoY (US$ Million), 2021-2032
Figure 29. Europe Top 5 Players ELISA Assay Service Revenue (US$ Million) in 2025
Figure 30. Europe ELISA Assay Service Revenue (US$ Million) by Application (2021-2032)
Figure 31. Germany ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 32. France ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 33. U.K. ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 34. Italy ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 35. Russia ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 36. Asia-Pacific ELISA Assay Service Revenue YoY (US$ Million), 2021-2032
Figure 37. Asia-Pacific Top 8 Players ELISA Assay Service Revenue (US$ Million) in 2025
Figure 38. Asia-Pacific ELISA Assay Service Revenue (US$ Million) by Application (2021-2032)
Figure 39. Indonesia ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 40. Japan ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 41. South Korea ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 42. Australia ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 43. India ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 44. Indonesia ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 45. Vietnam ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 46. Malaysia ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 47. Philippines ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 48. Singapore ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 49. Central and South America ELISA Assay Service Revenue YoY (US$ Million), 2021-2032
Figure 50. Central and South America Top 5 Players ELISA Assay Service Revenue (US$ Million) in 2025
Figure 51. Central and South America ELISA Assay Service Revenue (US$ Million) by Application (2021-2032)
Figure 52. Brazil ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 53. Argentina ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 54. Middle East and Africa ELISA Assay Service Revenue YoY (US$ Million), 2021-2032
Figure 55. Middle East and Africa Top 5 Players ELISA Assay Service Revenue (US$ Million) in 2025
Figure 56. Middle East and Africa ELISA Assay Service Revenue (US$ Million) by Application (2021-2032)
Figure 57. GCC Countries ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 58. Israel ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 59. Egypt ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 60. South Africa ELISA Assay Service Revenue (US$ Million), 2021-2032
Figure 61. ELISA Assay Service Value Chain Mapping
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global ELISA Assay Service market?
The top companies in the global ELISA Assay Service market are Boster Bio、RayBiotech、R&D Systems, Inc.
Related Reports
Global ELISA Assay Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global ELISA Assay Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 116
USD 4250.00
(Single User License)
Global ELISA Assay Service Market Research Report 2026
The global ELISA Assay Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 159
USD 2900.00
(Single User License)
ELISA Assay Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for ELISA Assay Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 142
USD 3950.00
(Single User License)
Global ELISA Assay Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global ELISA Assay Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 118
USD 4250.00
(Single User License)
Global ELISA Assay Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global ELISA Assay Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 161
USD 4900.00
(Single User License)
ELISA Assay Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for ELISA Assay Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 159
USD 3950.00
(Single User License)
Global ELISA Assay Service Market Research Report 2025
The global market for ELISA Assay Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-12
Pages: 108
USD 2900.00
(Single User License)
Global ELISA Assay Service Market Research Report 2024
The global ELISA Assay Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-08-15
Pages: 109
USD 2900.00
(Single User License)
Global and United States ELISA Assay Service Market Report & Forecast 2024-2030
The global ELISA Assay Service revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-08-15
Pages: 142
USD 4350.00
(Single User License)
Global ELISA Assay Service Market Insights, Forecast to 2030
The global ELISA Assay Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-08-15
Pages: 162
USD 4900.00
(Single User License)
Global ELISA Assay Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global ELISA Assay Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 116
USD 4250.00 (Single User License)Global ELISA Assay Service Market Research Report 2026
The global ELISA Assay Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 159
USD 2900.00 (Single User License)ELISA Assay Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for ELISA Assay Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 142
USD 3950.00 (Single User License)Global ELISA Assay Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global ELISA Assay Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 118
USD 4250.00 (Single User License)Global ELISA Assay Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global ELISA Assay Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 161
USD 4900.00 (Single User License)ELISA Assay Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for ELISA Assay Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 159
USD 3950.00 (Single User License)Global ELISA Assay Service Market Research Report 2025
The global market for ELISA Assay Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-12
Pages: 108
USD 2900.00 (Single User License)Global ELISA Assay Service Market Research Report 2024
The global ELISA Assay Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-08-15
Pages: 109
USD 2900.00 (Single User License)Global and United States ELISA Assay Service Market Report & Forecast 2024-2030
The global ELISA Assay Service revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-08-15
Pages: 142
USD 4350.00 (Single User License)Global ELISA Assay Service Market Insights, Forecast to 2030
The global ELISA Assay Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-08-15
Pages: 162
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now